BD (Becton, Dickinson and Company), a leading global medical technology company, announced that it has completed the previously announced divestitures of its soft tissue core needle biopsy
product line and Aspira product line to Merit Medical Systems, Inc.
US-based medical technology company BD (Becton, Dickinson and Company) (NYSE: BDX) has closed the divestitures of its soft tissue core needle biopsy
product line and Aspira product line to US-based disposable medical device maker Merit Medical Systems, Inc.
The assets acquired are soft tissue core needle biopsy
products sold under the trade names of Achieve Programmable Automatic Biopsy System, Temno Biopsy System, Tru-Cut Biopsy Needles as well as Aspira Pleural Effusion Drainage Kits, and the Aspira Peritoneal Drainage System.
Guided fine needle aspiration cytology (FNAC) was performed in each case and core needle biopsy
was done whenever feasible.
Objective: To determine the frequency of expression of positive diagnostic marker alpha methylacyl-COA RACEMES (AMACR) in the examination of prostate needle biopsy
specimens from patients of adenocarcinoma prostate from a subset of Pakistani population.
Cytology, as well as further core needle biopsy
samples, revealed thyroid tissue infiltrated by blast-like cells with a high nuclear-to-cytoplasmic ratio, a fine chromatin pattern, and variable prominent nucleoli.
The core needle biopsy
segment dominated the global market in 2016, and is expected to maintain this trend throughout the analysis period, owing to the less invasive procedure compared to others and it provides more definitive diagnosis.
Tru cut needle biopsy
is performed in majority of the cases, however when the abnormality is very small, subtle or when seen only on the mammograms in the form of calcifications or only on the breast MRI, vacuum-assisted breast biopsies (VABB) are preferred as they increase the accuracy and sensitivity of getting a representative sample from the abnormal area.
Gleason score correlates with important pathological parameters at radical prostatectomy (e.
Imaging-guided core needle biopsy
has become a routine procedure because of its inherent medical and economic advantages.
The accuracy of diagnosis can be increased with a combination of clinical examination, imaging diagnostics, and fine needle aspiration cytology (FNAC) or core needle biopsy
, also known as triple test.
This report and forecast focus on the adoption patterns of biopsy guns, fine needle aspiration (FNA) devices, core needle biopsy
(CNB) devices, and vacuum-assisted biopsy (VAB) devices, as well as biopsy forceps and punches in the diagnosis of breast, prostate, lung, liver, colorectal, and thyroid cancers.